Key Considerations and Disclosure Challenges in Contested Scrip Takeovers

In M&A transactions, scrip deals are often used by bidders as they allow the target shareholders to retain part or full exposure to the underlying business and can be helpful in bridging the gap in value expectations, while reducing upfront cash paid by the bidder. As part of disclosure to target shareholders, it is customary […]

Section 641 in Action: Navigating the Early Stages of a Hostile Takeover

While schemes of arrangement remain the dominant structure used in public M&A transactions, there has been a resurgence of takeover bids in recent years. We expect to continue to see hostile takeovers in circumstances where bidders make ‘opportunistic’ offers in a lower priced market and misalignment between the bidder and target valuation expectations. Some would […]

Hamilton Locke Act on the Sale of Scentia Pty Ltd

Hamilton Locke is delighted to have advised on the $98,000,000 sale of Scentia Pty Ltd (Scentia) to Next Capital Pty Limited and The Silverfern Group. Scentia was established in 2015 and is a leading Australian education and training group which includes the Australian Institute of Management and the Australasian College of Health and Wellness. Commenting […]

Hamilton Locke advised Tryptamine Therapeutics Limited on its acquisition and backdoor listing of Tryp Therapeutics

Hamilton Locke advised Tryptamine Therapeutics Limited (previously Exopharm Limited) (Company) on its acquisition and backdoor listing of Tryp Therapeutics Inc., a biotechnology entity previously listed on the Canadian Securities Exchange. The acquisition occurred by way of a Canadian plan of arrangement and included a A$6,500,000 public offer. The Company is entering an exciting new field […]

7 Key Steps to Sell Your Business to Private Equity in Australia

Private capital markets have outperformed public equities in recent years, leading to an increase in asset allocation to private capital classes in Australia. Whilst M&A transaction volumes have remained depressed post-COVID-19, there remains a significant amount of ‘dry powder’ in the private equity sector waiting to be deployed. There are signs of green shoots in […]

The Role of WHS in Managing Risks to Workers Exacerbated by Climate Change

Climate change is exposing workers to significant health and safety risks by exacerbating existing climate-related hazards. As the challenge of climate change continues to unfold, businesses may be required to adapt their operations to ensure the continued health and safety of workers. Critically, businesses must adhere to WHS law and policy as the primary measure […]

ASX Compliance Update

Changes to ASX Listing Applications In a bid to enhance efficiency and clarity in the listing application process, the Australian Securities Exchange (ASX) has introduced several changes to its admission procedures, effective February 5, 2024. These changes set out in Compliance Update (no. 01/24) aim to simplify documentation requirements and improve compliance with spread and escrow […]

M&A Report: 2023 Year in Review and Future Outlook

In Mergermarket’s 2023 Global & Regional M&A Rankings, Hamilton Locke ranked 6th in Australia for the highest volume of M&A deals, with 69 deals valued at USD738 million. This is the firm’s highest Mergermarket ranking and a significant jump from 13th place in 2022. As part of our ongoing commitment to driving excellence in the […]

Hamilton Locke Advises EMVision on $15.28M Strategic Placement with Keysight Technologies

Hamilton Locke is pleased to have advised EMVision Medical Devices Limited (ASX: EMV) on its $15.28 million strategic placement with Keysight Technologies Inc (NYSE: KEYS). The deal represents a significant milestone for EMVision, positioning the company for accelerated growth, market penetration, and continued innovation in medical imaging technology. The investment will facilitate and fund EMVision’s […]

Hamilton Locke Assists on Successful Restructure of the Body Catalyst Group

Hamilton Locke recently advised Alan Walker and Glenn Livingstone of WLP Restructuring in their capacity as voluntary administrators of the Body Catalyst Group on the successful restructure of its body shaping and wellness treatment business. On 7 December 2023, 46 companies in the Body Catalyst Group, a non-invasive body sculpting cosmetic chain with clinics around […]